Pickering J G, Uniyal S, Ford C M, Chau T, Laurin M A, Chow L H, Ellis C G, Fish J, Chan B M
Department of Medicine (Cardiology), University of Western Ontario, London, Canada.
Circ Res. 1997 May;80(5):627-37. doi: 10.1161/01.res.80.5.627.
Fibroblast growth factor-2 (FGF-2) has been implicated in vascular smooth muscle cell (SMC) migration, a key process in vascular disease. We demonstrate here that FGF-2 promotes SMC motility by altering beta1 integrin-mediated interactions with the extracellular matrix (ECM). FGF-2 significantly increased surface expression of alpha2beta1, alpha3beta1, and alpha5beta1 integrins on human SMCs, as assessed by flow cytometry. The greatest increase was for the collagen-binding alpha2beta1 integrin. Despite this, FGF-2 did not increase SMC adhesion to type I collagen but instead promoted SMC elongation and SMC motility. The latter was evaluated by using a microchemotaxis chamber and by digital time-lapse video microscopy. Although FGF-2 was not chemotactic for human SMCs, cells preincubated with FGF-2 displayed a 3.1-fold increase in migration to the undersurface of porous type I collagen-coated membranes and a 2.1-fold increase in migration speed on collagen. Furthermore, chemotaxis to platelet-derived growth factor-BB on collagen was significantly greater in SMCs exposed to FGF-2. FGF-2-induced elongation and migration on collagen were inhibited by a blocking anti-alpha2beta1 antibody; however, SMC adhesion to collagen was unaffected. SMC migration on fibronectin was also enhanced by FGF-2, although less prominently: migration through porous membranes increased 1.8-fold, and migration speed increased 1.3-fold. Also, FGF-2 completely disassembled the smooth muscle alpha-actin-containing stress fiber network contemporaneously with the change in integrin expression and cell shape. We conclude that (1) exogenous FGF-2 promotes SMC migration and potentiates chemotaxis to PDGF-BB; (2) the promigratory effect of FGF-2 is especially prominent on type I collagen and is mediated by upregulation of alpha2beta1 integrin; and (3) FGF-2 disassembles actin stress fibers, which may promote differential utilization of alpha2beta1 integrin for motility but not adhesion. This dynamic SMC-ECM interplay may be an important mechanism by which FGF-2 facilitates SMC motility in vivo.
成纤维细胞生长因子-2(FGF-2)与血管平滑肌细胞(SMC)迁移有关,而SMC迁移是血管疾病中的一个关键过程。我们在此证明,FGF-2通过改变β1整合素介导的与细胞外基质(ECM)的相互作用来促进SMC的运动。通过流式细胞术评估,FGF-2显著增加了人SMC上α2β1、α3β1和α5β1整合素的表面表达。增加最为显著的是与胶原蛋白结合的α2β1整合素。尽管如此,FGF-2并未增加SMC与I型胶原蛋白的黏附,而是促进了SMC的伸长和运动。后者通过使用微趋化性小室和数字延时视频显微镜进行评估。虽然FGF-2对人SMC没有趋化作用,但预先用FGF-2孵育的细胞向多孔I型胶原蛋白包被膜下表面的迁移增加了3.1倍,在胶原蛋白上的迁移速度增加了2.1倍。此外,在暴露于FGF-2的SMC中,对胶原蛋白上血小板衍生生长因子-BB的趋化作用显著增强。FGF-2诱导的在胶原蛋白上的伸长和迁移被阻断性抗α2β1抗体抑制;然而,SMC与胶原蛋白的黏附不受影响。FGF-2也增强了SMC在纤连蛋白上的迁移,尽管不太明显:通过多孔膜的迁移增加了1.8倍,迁移速度增加了1.3倍。此外,FGF-2在整合素表达和细胞形状改变的同时,完全拆散了含有平滑肌α-肌动蛋白的应力纤维网络。我们得出结论:(1)外源性FGF-2促进SMC迁移并增强对PDGF-BB的趋化作用;(2)FGF-2的促迁移作用在I型胶原蛋白上尤为突出,并由α2β1整合素的上调介导;(3)FGF-2拆散肌动蛋白应力纤维,则可能促进α2β1整合素对运动而非黏附的不同利用。这种动态的SMC-ECM相互作用可能是FGF-2在体内促进SMC运动的重要机制。